Followers | 88 |
Posts | 8196 |
Boards Moderated | 0 |
Alias Born | 06/17/2013 |
Wednesday, September 21, 2022 11:56:23 AM
Codycrusher wrote: ?Wed Sep 21, 2022 4:33 am
I’m curious on the status of general ARDS, that is a big move and it’s very important for phase 3 because you always said the endgame here is to go for general ARDS in phase 3 and for commercialization, so I know how important that is for these trials and all.
I’m excited to see you get the approval and the announcement, I assume it should be any day now because you filed last month and made the PR on the 25th and they have to respond within 30 days I believe so that leaves the end of this month as the timeline and I’m very excited for that.
We have not heard back from FDA yet on amendment but that is just part of the process. Oh I know people want to dig up regulations and then fixate on some number of days the reg's speak of but do what I do and you will see that those things are just ink on paper because they can stop and restart the clock as needed so we just wait patiently. Here's what you need to know and everything in between is called patience/ the minute FDA signed off on our form 1571 that converted the academic phase 2 to a commercial phase 3, the trial began and the trial will continue until we have a BLA with FDA for use in the general population with diagnosed ARDS. Thats it in a nutshell. So everyone needs to come to grips with that. There isn't much else that will come out before BLA other than our published results in peer reviewed journal which will set us up for BLA application. Thats it.
We have a clinical trial to conduct in CTE and Breast Cancer and COPD and no one even talks about that - we just filed a new patent to license to Campbell (note to self, draft license and send to Kalina). Were about to launch the first of several new spin-offs to accommodate those IND's and working on many new patents yet to be filed.
I hope you all can find excitement in other things while we do our things behind the scenes...
https://forum.therapeuticsolutionsint.com/viewtopic.php?t=384&start=15
Recent TSOI News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 07:15:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 07:12:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 10:25:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 11:16:15 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/08/2024 05:15:25 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/06/2024 11:34:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 08:42:55 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/17/2024 11:15:01 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/04/2024 09:03:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 07:44:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:39:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2023 11:17:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2023 11:13:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 06:50:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 05:44:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:24:52 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 11:10:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:29:10 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM